BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 208723)

  • 61. Properties of the phosphoribosylpyrophosphate-glutamine amidotransferase of the human leucemic cells.
    Becher H; Gerok W
    Adv Exp Med Biol; 1977; 76A():92-8. PubMed ID: 855737
    [No Abstract]   [Full Text] [Related]  

  • 62. Role of nucleosides, 5-phosphoribosyl-1-pyrophosphate, and ribose 1-phosphate in the biosynthesis of phosphosphingolipids in Bacteroides melaninogenicus.
    Lev M; Milford AF
    Arch Biochem Biophys; 1978 Jan; 185(1):82-7. PubMed ID: 23730
    [No Abstract]   [Full Text] [Related]  

  • 63. A possible role for 5-phosphoribosyl 1-pyrophosphate in the stimulation of uterine purine nucleotide synthesis in response to oestradiol-17 .
    Oliver JM
    Biochem J; 1972 Jul; 128(4):771-7. PubMed ID: 4344697
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Activities of amidophosphoribosyltransferase and purine phosphoribosyltransferases in developing rat brain.
    Allsop J; Watts RW
    Adv Exp Med Biol; 1980; 122A():361-6. PubMed ID: 7424658
    [No Abstract]   [Full Text] [Related]  

  • 65. Altered 5-phosphoribosyl 1-pyrophosphate amidotransferase activity in 6-thioguanine-resistant HL-60 human acute promyelocytic leukemia cells.
    Ishiguro K; Sartorelli AC
    Cancer Res; 1984 Sep; 44(9):3679-85. PubMed ID: 6589043
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Hepatic glutamine-5-phosphoribosyl-1-pyrophosphate amidotransferase and glucocorticoids].
    Di Stefano A; Pizzichini M; Paffetti A; Marinello E
    Boll Soc Ital Biol Sper; 1985 May; 61(5):671-5. PubMed ID: 4027040
    [No Abstract]   [Full Text] [Related]  

  • 67. Methotrexate inhibits the first committed step of purine biosynthesis in mitogen-stimulated human T-lymphocytes: a metabolic basis for efficacy in rheumatoid arthritis?
    Fairbanks LD; Rückemann K; Qiu Y; Hawrylowicz CM; Richards DF; Swaminathan R; Kirschbaum B; Simmonds HA
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):143-52. PubMed ID: 10432311
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacologic regulation of the early steps of purine biosynthesis in Burkitt lymphoma cells and in Ehrlich ascites tumor cells.
    Reem GH
    J Pharmacol Exp Ther; 1974 Oct; 191(1):1-9. PubMed ID: 4371231
    [No Abstract]   [Full Text] [Related]  

  • 69. De novo purine synthesis in human lymphocytes.
    Rowe PB; McCairns E; Sauer D; Fahey D
    Adv Exp Med Biol; 1984; 165 Pt A():421-6. PubMed ID: 6720409
    [No Abstract]   [Full Text] [Related]  

  • 70. Metabolic defects of primary hyperuricemia and gout.
    Wyngaarden JB
    Am J Med; 1974 May; 56(5):651-64. PubMed ID: 4363475
    [No Abstract]   [Full Text] [Related]  

  • 71. [Regulation of purine nucleotide biosynthesis in mutant Saccharomyces cerevisiae yeasts with increased sensitivity of the pathway for de novo synthesis to inhibition by exogenous guanine].
    Smolina VS; Andrianova VM; Bekker ML
    Genetika; 1978 Sep; 14(9):1495-1502. PubMed ID: 214373
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Properties of erythrocyte purine phosphoribosyltransferases in partial hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Sperling O; Boer P; De Vries A
    Adv Exp Med Biol; 1973; 41():211-3. PubMed ID: 4791193
    [No Abstract]   [Full Text] [Related]  

  • 73. Stabilization by PRPP of cellular purine phosphoribosyltransferases against inactivation by freezing and thawing. Study of normal and hypoxanthine-guanine phosphoribosyltransferase deficient human fibroblasts.
    Zoref E; Sperling O; De Vries A
    Adv Exp Med Biol; 1973; 41():15-8. PubMed ID: 4799658
    [No Abstract]   [Full Text] [Related]  

  • 74. Regulation of the synthesis of 5-phosphoribosyl-I-pyrophosphate in intact red blood cells and in cell-free preparations.
    Hershko A; Razin A; Mager J
    Biochim Biophys Acta; 1969 Jun; 184(1):64-76. PubMed ID: 4307186
    [No Abstract]   [Full Text] [Related]  

  • 75. Observations of altered intracellular phosphoribosylpyrophosphate (PP-ribose-P) in human disease.
    Fox IH; Kelley WN
    Adv Exp Med Biol; 1974; 41():471-8. PubMed ID: 4364979
    [No Abstract]   [Full Text] [Related]  

  • 76. Glutamine-dependent carbamoyl phosphate synthetase: polyamines inhibit the activity and modify the activating effect of 5-phosphoribosyl 1-pyrophosphate.
    Mori M; Tatibana M
    Biochem Biophys Res Commun; 1975 Nov; 67(1):287-93. PubMed ID: 173306
    [No Abstract]   [Full Text] [Related]  

  • 77. Guanylyl 2'-5' guanosine as an inhibitor of ribonuclease T1.
    White MD; Rapoport S; Lapidot Y
    Biochem Biophys Res Commun; 1977 Aug; 77(3):1084-7. PubMed ID: 197947
    [No Abstract]   [Full Text] [Related]  

  • 78. Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties.
    Holmes EW; McDonald JA; McCord JM; Wyngaarden JB; Kelley WN
    J Biol Chem; 1973 Jan; 248(1):144-50. PubMed ID: 4348202
    [No Abstract]   [Full Text] [Related]  

  • 79. [Phosphate inhibition of the conversion of ribose-1-phosphate--a product of purine nucleoside phosphorylase splitting in the phosphoribomutase reaction].
    Golovatskiĭ ID; Tsegel'skiĭ AA
    Ukr Biokhim Zh (1978); 1987; 59(5):45-9. PubMed ID: 2825385
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Kinetic studies of inhibition of adenine phosphoribosyltransferase by guanylate.
    Henderson JF; Hori M; Palser HM; Gadd RE
    Biochim Biophys Acta; 1972 Apr; 268(1):70-6. PubMed ID: 4336171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.